R&G PharmaStudies Co., Ltd. (SHE:301333)
China
· Delayed Price · Currency is CNY 66.19
-0.09 (-0.14%)
Mar 6, 2026, 4:00 PM EST
R&G PharmaStudies Company Description
R&G PharmaStudies Co., Ltd. operates as a clinical trial outsourcing service provider in China and internationally.
It provides drug clinical research and development integrated services. The company’s services include clinical trial operation, clinical trial site management, biological sample testing, data management and statistical analysis, clinical trial consulting, and clinical pharmacology services.
It serves pharmaceutical and medical device companies, and scientific research institutions. The company was founded in 2008 and is headquartered in Beijing, China.
R&G PharmaStudies Co., Ltd.
| Country | China |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,208 |
| CEO | Jie Wu |
Contact Details
Address: North Tower Beijing, 100048 China | |
| Website | rg-pharma.com |
Stock Details
| Ticker Symbol | 301333 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005K44 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Jie Wu M.B.A. | Chairman and GM |
| Qian Zhao | Chief Financial Officer and Accounting Supervisor |
| Leyan Teng | Chief Operating Officer, Senior Vice President and Director |
| Wei Wang EMBA | Deputy GM and Director |
| Jigang Li M.B.A. | Senior Vice President and Chief Medical Officer |
| Dr. Shuqi Li | Senior Vice President, Board Secretary and Director |
| Dr. Ping Liu | Deputy General Manager |